Imatinib Completed Phase 2 Trials for Chronic Myelomonocytic Leukemia / Essential Thrombocythemia (ET) / Polycythemia Vera (PV) / Primary Myelofibrosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00430066Effects of Imatinib Mesylate in Polycythemia Vera
NCT01120821Treatment of Polycythemia Vera With Gleevec
NCT00039416Imatinib Mesylate in Treating Patients With Myelofibrosis